This method ensures the injection works efficiently and quickly to support your weight loss program
A separate product, semaglutide subcutaneous injection (Wegovy), is indicated as an adjunct to lifestyle modifications for weight loss and chronic weight management in obese (BMI 30 kg/m2 or greater) or overweight adults (BMI 27 kg/m2 or greater) with at least 1 weight-related comorbid condition (e.g., hypertension, type 2 diabetes mellitus, or dyslipidemia)
With so many clinics offering different prices and treatment packages, it can be confusing to know whats fair or whats included
Securely sealed and packaged to preserve integrity during storage and transit
Originally investigated for its potential to combat obesity, metabolic syndrome, and age-related decline, this NNMT (nicotinamide N-methyltransferase) inhibitor has shown promise in boosting fat metabolism, preserving lean muscle mass, and increasing energy efficiency
Not for human consumption, medical, veterinary, or diagnostic use